Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Chimeric Antigen Receptor T Cells (CAR-T)
95%
Cell Therapy
47%
Death Receptor
47%
BCP-ALL
47%
Receptor Expression
47%
Cell-to-cell
47%
CD19 chimeric Antigen Receptor T Cells
47%
T Helper 17 Cells (Th17)
47%
Immune-related Adverse Events (IrAEs)
47%
BNT162b2
47%
Vaccination
47%
COVID-19
47%
Pediatric Cancer Patients
47%
Immune Response
47%
Diffuse Midline Glioma
47%
Pediatric
47%
Oncolytic Virus
47%
Checkpoint Inhibition
47%
T Cell Activation
47%
Non-response
47%
T Cell Response
23%
Tumor Protein p53 (TP53)
17%
Best Response
15%
Death Receptor 5
11%
T Cell Cytotoxicity
11%
Fas Receptor
11%
MR1T Cells
11%
MR1-restricted T Cells
11%
Relapsed/refractory Leukemia
11%
Fast 3D Imaging
11%
Immunosuppression
11%
Live 3D
11%
Data-informed
11%
Liquid Tumors
11%
Gastrointestinal Immune-related Adverse Events
9%
T Cells
7%
Interferon-γ
7%
Immunization
7%
Vaccine Response
7%
Binding Antibodies
7%
Children with Cancer
7%
International Units
7%
SARS-CoV-2 Spike
7%
Chemoimmunotherapy
7%
Active Cancer Treatment
7%
Serum Concentration
7%
2-dose
7%
Antibody Level
7%
Anti-SARS-CoV-2
7%
Antibody Response
7%
Immunology and Microbiology
T Cell
100%
Chimeric Antigen Receptor T-Cell
95%
Immune Response
52%
Cell Function
47%
B Cell
47%
Precursor
47%
Death Receptor
47%
P53
47%
CD19
47%
Immunotherapy
47%
COVID-19 Vaccination
47%
Steroid
47%
Oncolytic Virus
47%
Coculture
42%
Immunocompetent Cell
35%
Chimeric Antigen Receptor T-Cell Therapy
27%
Intravenous Immunoglobulin
23%
Organoid
23%
Spike
23%
Tumor Cell
18%
Cytotoxicity
13%
Infection
13%
Immunosuppression
13%
Infectious Disease
13%
Cell Culture
11%
Binding Antibody
11%
Interferon Gamma
11%
COVID-19
11%
Blood Level
11%
Antibody Response
11%
Severe Acute Respiratory Syndrome Coronavirus 2
11%
Colitis
8%
Cytotoxic T-Cell
8%
Mucosal-Associated Invariant T Cell
7%
Expression Analysis
6%
Ectopic Expression
6%
Leukemia Cell Line
6%
Xenograft
6%
Overall Survival
6%
Cell Line
6%
Virus Concentration
6%
Gene Expression
6%
Cell Activity
6%
RNA Sequence
6%
Chimeric Antigen Receptor
6%
Adenoviridae
6%
Glioma Cell
6%
Cytokine
6%
Reoviridae
6%
Cell Cycle
6%
Medicine and Dentistry
Pediatric Cancer
47%
T Cell
47%
Immune-Related Adverse Events
47%
Steroid
47%
Human Leukocyte Antigen
23%
Cancer
23%
Tumor
23%
Leukemia
23%
Cell Therapy
15%
Malignant Neoplasm
15%
Ganglioglioma
15%
T Lymphocyte Receptor
15%
Pediatrics
15%
In Vitro
15%
Immunotherapy
15%
Cytotoxicity
7%
Neoplasm
7%
Messenger RNA
7%
Tumor Model
7%
Real-Time Polymerase Chain Reaction
7%
Synapsin I
7%
Survival Rate
7%
RNA Sequence
7%
Mucosal-Associated Invariant T Cell
7%
Intracranial Tumor
7%
Metabolite
7%
Major Histocompatibility Complex
7%